Topiramate
[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate
Molecular Identity
Topiramate
[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate
PubChem CID: 5284627
Topiramate can cause developmental toxicity according to state or federal government labeling requirements.
2D Structure
Properties
C12H21NO8S
Molecular Formula
339.36
Molecular Weight
g/mol
339.0988
Exact Mass
Da
-0.8
XLogP
Drug-like (Lipinski: < 5)
124
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
9
H-Bond Acceptors
556
Complexity
SMILES
Canonical SMILES
SMILES: CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)CIsomeric SMILES
SMILES: CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)CSynonyms(20)
topiramate97240-79-4TopamaxEpitomaxTopamax SprinkleTopinaTipiramateTopiramatoTopiramatumEpitomaTopimaxTopomaxMcN-4853TipiramatoTopamac
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Topiramate
Loading drug network...